Player Avatar georacer (< 20) Submitted: 7/20/2011 9:56:23 PM : Underperform Start Price: $50.47 VRTX Score: -80.77

Vertex's blockbuster drug Telaprevir, which is used for the treatment of Hepatitis C has a 1 in 3 chance of causing a scarring rash that is so bad that treatment must be stopped. Another drug that has a similar mechanism of action that has just been released, Boceprevir, is also used for the treatment of Hepatitis C is also effective without the scarring rash. Physicians will chose Boceprevir as they do not want the additional burden of grading patients scars as well as the high likelihood of stopping treatment.

Featured Broker Partners